drugset / Trial / NCT01220063
RSHF in Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to study stereotactic radiotherapy with a dose of 40 Gy in 4 fractions over 2 weeks with concomitant 40 mg/m2 of irinotecan (1st and 3rd irradiation session).
Timeline
- Start
- 2007-10-19
- Primary completion
- 2018-08
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 40 mg/m2 | — |